| Pleasant Acres Rehabilitation And Nursing Center | |
| 118 Pleasant Acres Rd,rd7, York, Pennsylvania 17402 | |
| (717) 840-7100 | |
| Name | Pleasant Acres Rehabilitation And Nursing Center |
|---|---|
| Location | 118 Pleasant Acres Rd,rd7, York, Pennsylvania |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 375 |
| Occupancy Rate | 77.09% |
| Medicare ID (CCN) | 395290 |
| Legal Business Name | Pleasant Acres Operating Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1619459351 |
| Organization Name | PLEASANT ACRES OPERATING, LLC |
| Address | 118 Pleasant Acres Rd, York, PA 17402 |
| Phone Number | 717-840-7100 |
News Archive
Although the link between early screening and prostate cancer survival is well established, men are less likely to go for early screening unless they have a wife or significant other living with them, according to a study published in Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
Eli Lilly and Company today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District of Indiana that the company's method-of-use patents for Evista® (raloxifene HCl tablets) are valid. These patents provide protection for Evista in the U.S. through March of 2014.
Testicular germ cell cancer, a disease that is rare but growing in incidence in men in the United States, is considered to be among the most curable of solid tumors. Now researchers from the University of North Carolina Lineberger Comprehensive Cancer Center and a consortium of institutions have discovered the genetic and genomic characteristics that define the disease.
In a Maternal & Child Nutrition analysis of published studies on the dietary habits of women who were trying to conceive or were pregnant, most studies indicated that women do not meet nutritional recommendations for vegetable, cereal grain, or folate intake.
According to the British government agency responsible for medical safety, the Medicines and Healthcare Products Regulatory Agency (MHRA), no evidence has been found to suggest there were any problems with the manufacturing of a drug which left six volunteers seriously ill.
› Verified 6 days ago
| NPI Number | 1790757607 |
| Organization Name | COUNTY OF YORK |
| Doing Business As | PLEASANT ACRES NURSING & REHABILITATION CENTER |
| Address | 118 Pleasant Acres Rd, York, PA 17402 |
| Phone Number | 717-840-7103 |
News Archive
Although the link between early screening and prostate cancer survival is well established, men are less likely to go for early screening unless they have a wife or significant other living with them, according to a study published in Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
Eli Lilly and Company today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District of Indiana that the company's method-of-use patents for Evista® (raloxifene HCl tablets) are valid. These patents provide protection for Evista in the U.S. through March of 2014.
Testicular germ cell cancer, a disease that is rare but growing in incidence in men in the United States, is considered to be among the most curable of solid tumors. Now researchers from the University of North Carolina Lineberger Comprehensive Cancer Center and a consortium of institutions have discovered the genetic and genomic characteristics that define the disease.
In a Maternal & Child Nutrition analysis of published studies on the dietary habits of women who were trying to conceive or were pregnant, most studies indicated that women do not meet nutritional recommendations for vegetable, cereal grain, or folate intake.
According to the British government agency responsible for medical safety, the Medicines and Healthcare Products Regulatory Agency (MHRA), no evidence has been found to suggest there were any problems with the manufacturing of a drug which left six volunteers seriously ill.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Although the link between early screening and prostate cancer survival is well established, men are less likely to go for early screening unless they have a wife or significant other living with them, according to a study published in Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
Eli Lilly and Company today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District of Indiana that the company's method-of-use patents for Evista® (raloxifene HCl tablets) are valid. These patents provide protection for Evista in the U.S. through March of 2014.
Testicular germ cell cancer, a disease that is rare but growing in incidence in men in the United States, is considered to be among the most curable of solid tumors. Now researchers from the University of North Carolina Lineberger Comprehensive Cancer Center and a consortium of institutions have discovered the genetic and genomic characteristics that define the disease.
In a Maternal & Child Nutrition analysis of published studies on the dietary habits of women who were trying to conceive or were pregnant, most studies indicated that women do not meet nutritional recommendations for vegetable, cereal grain, or folate intake.
According to the British government agency responsible for medical safety, the Medicines and Healthcare Products Regulatory Agency (MHRA), no evidence has been found to suggest there were any problems with the manufacturing of a drug which left six volunteers seriously ill.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 3 |
| Total Amount of Fines in Dollars | $80919 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 25.64 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 10.99 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 35.32 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.61 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.01 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.68 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.24 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.58 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 23.46 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 83.48 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 3.21 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 37.58 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 22.62 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.81 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.64 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 72.35 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 80.18 | 82.93 |
News Archive
Although the link between early screening and prostate cancer survival is well established, men are less likely to go for early screening unless they have a wife or significant other living with them, according to a study published in Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
Eli Lilly and Company today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District of Indiana that the company's method-of-use patents for Evista® (raloxifene HCl tablets) are valid. These patents provide protection for Evista in the U.S. through March of 2014.
Testicular germ cell cancer, a disease that is rare but growing in incidence in men in the United States, is considered to be among the most curable of solid tumors. Now researchers from the University of North Carolina Lineberger Comprehensive Cancer Center and a consortium of institutions have discovered the genetic and genomic characteristics that define the disease.
In a Maternal & Child Nutrition analysis of published studies on the dietary habits of women who were trying to conceive or were pregnant, most studies indicated that women do not meet nutritional recommendations for vegetable, cereal grain, or folate intake.
According to the British government agency responsible for medical safety, the Medicines and Healthcare Products Regulatory Agency (MHRA), no evidence has been found to suggest there were any problems with the manufacturing of a drug which left six volunteers seriously ill.
› Verified 6 days ago
Promedica Skilled Nrsg And Rehab (kingston Court) Location: 2400 Kingston Court, York, Pennsylvania 17402 Phone: (717) 755-8811 | |
Colonial Manor Nursing Home Location: 970 Colonial Avenue, York, Pennsylvania 17403 Phone: (717) 845-2661 | |
Pleasant Acres Rehabilitation And Nursing Center Location: 118 Pleasant Acres Rd,rd7, York, Pennsylvania 17402 Phone: (717) 840-7100 | |
Promedica Skilled Nrsg And Rehab (york South) Location: 200 Pauline Drive, York, Pennsylvania 17402 Phone: (717) 741-0824 | |
Promedica Skilled Nrsg And Rehab (york North) Location: 1770 Barley Road, York, Pennsylvania 17408 Phone: (717) 767-6530 |